This HTML5 document contains 190 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

Prefix	IRI
n9	http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0107734/price/
n18	http://linked.opendata.cz/resource/sukl/roa/
n2	http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/
dcterms	http://purl.org/dc/terms/
n3	http://linked.opendata.cz/ontology/sukl/
skos	http://www.w3.org/2004/02/skos/core#
n19	http://linked.opendata.cz/resource/sukl/indgroup/
n16	http://linked.opendata.cz/resource/sukl/packing/
n14	http://linked.opendata.cz/resource/sukl/company/
n20	http://linked.opendata.cz/resource/sukl/active-ingredient/
n6	http://linked.opendata.cz/resource/sukl/specialization-restriction/http://linked.opendata.cz/ontology/odcs/tabular/
n7	http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0107734/price-of-originator/
rdf	http://www.w3.org/1999/02/22-rdf-syntax-ns#
n11	http://linked.opendata.cz/resource/sukl/registration-state/
n10	http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0107734/reimbursement/
xsdh	http://www.w3.org/2001/XMLSchema#
n15	http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0107734/
n5	http://www.sukl.cz/modules/medication/
n4	http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0107734/core-reimbursement/
n17	http://linked.opendata.cz/resource/atc/
n8	http://linked.opendata.cz/resource/sukl/df/

Statements

Subject Item

n2:0107734

rdf:type

n3:MedicinalProductPackaging

dcterms:title

FRAGMIN 5000 M.J.(ANTI-XA)/0,2 ML

skos:notation

0107734

n3:hasATCCode

n17:B01AB04

n3:hasActiveIngredient

n20:DALTEPARINUM-NATRICUM

n3:hasDefinedDailyDose

n15:ddd

n3:hasDosageForm

n8:SOL-ISP-INJ

n3:hasPackagingSize

10X0.2ML

n3:hasPacking

n16:ISP

n3:hasRegistrationHolder

n14:PFXCZ

n3:hasRegistrationState

n11:R

n3:hasRouteOfAdministration

n18:INJ

n3:hasStrength

25KU/ML

n3:hasIndicationGroup

n19:16

n3:hasSpecializationRestriction

n6:blank-cell

n3:containsDefinedDailyDoses

20.0

n3:hasRegistrationCode

16/ 400/92-D/C

n3:hasTitleSupplement

INJ SOL ISP 10X0.2ML/5KU

n3:containsUsualTherapeuticalDailyDoses

10

n3:hasBreakMarketingDate

2014-11-24+01:00 2013-06-03+02:00

n3:hasCoreReimbursementSpecification

n4:2013-02-01 n4:2013-03-01 n4:2013-01-01 n4:2013-01-05 n4:2015-07-01 n4:2015-07-02 n4:2015-05-01 n4:2015-06-01 n4:2013-09-01 n4:2013-10-01 n4:2013-08-01 n4:2013-08-03 n4:2013-06-01 n4:2013-07-01 n4:2013-04-01 n4:2013-05-01 n4:2014-05-01 n4:2014-06-01 n4:2014-03-01 n4:2014-04-01 n4:2014-01-01 n4:2014-02-01 n4:2013-11-01 n4:2013-12-01 n4:2014-10-02 n4:2014-11-01 n4:2014-09-01 n4:2014-10-01 n4:2014-07-03 n4:2014-08-01 n4:2014-06-13 n4:2014-07-01 n4:2015-04-01 n4:2015-04-02 n4:2015-02-01 n4:2015-03-01 n4:2015-01-01 n4:2015-01-13 n4:2014-11-19 n4:2014-12-01

n3:hasIndicationRestriction

P

n3:hasPriceOfOriginatorSpecification

n7:2014-07-03 n7:2014-08-01 n7:2014-06-13 n7:2014-07-01 n7:2014-10-02 n7:2014-11-01 n7:2014-09-01 n7:2014-10-01 n7:2014-01-01 n7:2014-02-01 n7:2013-11-01 n7:2013-12-01 n7:2014-05-01 n7:2014-06-01 n7:2014-03-01 n7:2014-04-01 n7:2013-06-01 n7:2013-07-01 n7:2013-04-01 n7:2013-05-01 n7:2013-09-01 n7:2013-10-01 n7:2013-08-01 n7:2013-08-03 n7:2013-02-01 n7:2013-03-01 n7:2013-01-01 n7:2013-01-05 n7:2015-07-01 n7:2015-07-02 n7:2015-05-01 n7:2015-06-01 n7:2015-01-01 n7:2015-01-13 n7:2014-11-19 n7:2014-12-01 n7:2015-04-01 n7:2015-04-02 n7:2015-02-01 n7:2015-03-01

n3:hasPriceSpecification

n9:2014-03-01 n9:2014-04-01 n9:2014-05-01 n9:2014-06-01 n9:2013-11-01 n9:2013-12-01 n9:2014-01-01 n9:2014-02-01 n9:2013-08-01 n9:2013-08-03 n9:2013-09-01 n9:2013-10-01 n9:2013-04-01 n9:2013-05-01 n9:2013-06-01 n9:2013-07-01 n9:2013-01-01 n9:2013-01-05 n9:2013-02-01 n9:2013-03-01 n9:2015-05-01 n9:2015-06-01 n9:2015-07-01 n9:2015-07-02 n9:2015-02-01 n9:2015-03-01 n9:2015-04-01 n9:2015-04-02 n9:2014-11-19 n9:2014-12-01 n9:2015-01-01 n9:2015-01-13 n9:2014-09-01 n9:2014-10-01 n9:2014-10-02 n9:2014-11-01 n9:2014-06-13 n9:2014-07-01 n9:2014-07-03 n9:2014-08-01

n3:hasReimbursementSpecification

n10:2013-09-01 n10:2013-10-01 n10:2013-08-01 n10:2013-08-03 n10:2013-06-01 n10:2013-07-01 n10:2013-04-01 n10:2013-05-01 n10:2013-02-01 n10:2013-03-01 n10:2013-01-01 n10:2013-01-05 n10:2015-07-01 n10:2015-07-02 n10:2015-05-01 n10:2015-06-01 n10:2015-04-01 n10:2015-04-02 n10:2015-02-01 n10:2015-03-01 n10:2015-01-01 n10:2015-01-13 n10:2014-11-19 n10:2014-12-01 n10:2014-10-02 n10:2014-11-01 n10:2014-09-01 n10:2014-10-01 n10:2014-07-03 n10:2014-08-01 n10:2014-06-13 n10:2014-07-01 n10:2014-05-01 n10:2014-06-01 n10:2014-03-01 n10:2014-04-01 n10:2014-01-01 n10:2014-02-01 n10:2013-11-01 n10:2013-12-01

n3:hasResumedMarketingDate

2013-07-19+02:00

n3:hasUsualTherapeuticalDailyDose

n15:utdd

n3:pilFile

http%3A%2F%2Fwww.sukl.cz%2Fmodules%2Fmedication%2Fdownload.php%3Ffile%3DPI12745.pdf%26type%3Dpil%26as%3Dfragmin-5000-m-j-anti-xa-0-2-ml-pil

n3:pilUri

n5:download.php?file=PI12745.pdf&type=pil&as=fragmin-5000-m-j-anti-xa-0-2-ml-pil

n3:spcFile

http%3A%2F%2Fwww.sukl.cz%2Fmodules%2Fmedication%2Fdownload.php%3Ffile%3DSPC12746.pdf%26type%3Dspc%26as%3Dfragmin-5000-m-j-anti-xa-0-2-ml-spc

n3:spcUri

n5:download.php?file=SPC12746.pdf&type=spc&as=fragmin-5000-m-j-anti-xa-0-2-ml-spc

n3:textOnTheWrapFile

http%3A%2F%2Fwww.sukl.cz%2Fmodules%2Fmedication%2Fdownload.php%3Ffile%3DOBAL37438.pdf%26type%3Dobal%26as%3Dfragmin-5000-m-j-anti-xa-0-2-ml-obal

n3:textOnTheWrapUri

n5:download.php?file=OBAL37438.pdf&type=obal&as=fragmin-5000-m-j-anti-xa-0-2-ml-obal